Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

4-(2-amino-3-((1-(2-benzo(b)thiophen-3-yl)-1-(benzylcarbamoyl)ethylcarbamoyl-2-(biphenyl-4-yl)ethylcarbamoyl)-3-sulfanylpropyl))benzoic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
4-(2-amino-3-((1-(2-benzo(b)thiophen-3-yl)-1-(benzylcarbamoyl)ethylcarbamoyl-2-(biphenyl-4-yl)ethylcarbamoyl)-3-sulfanylpropyl))benzoic acid
Unique ID
C478620
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C478620
Entry Term(s)
ylgucpd85
Registry Numbers
0
Heading Mapped to
*Benzoates
*Oligopeptides
*Sulfur Compounds
Frequency
1
Note
a botulinum neurotoxin B inhibitor; structure in first source
Source
J Med Chem 2003 Oct 23;46(22):4648-56
Date of Entry
2003/11/08
Revision Date
2012/08/24
4-(2-amino-3-((1-(2-benzo(b)thiophen-3-yl)-1-(benzylcarbamoyl)ethylcarbamoyl-2-(biphenyl-4-yl)ethylcarbamoyl)-3-sulfanylpropyl))benzoic acid Preferred
page delivered in 0.004s